Company newsMRNA
Explain this story: Moderna Stock Trends After Hours - Moderna (NASDAQ:MRNA), Merck & Co (NYSE:MRK)
Moderna (MRNA) shares are trending after hours following an announcement regarding its investigational mRNA-based individualized neoantigen therapy, intismeran autogene. The company will present three abstracts, including Phase 3 trial data evaluating intismeran with Merck & Co.'s (MRK) pembrolizumab, at the European Society for Medical Oncology Congress 2026. MRNA stock saw a significant jump of 6.98% during regular trading and edged higher in after-hours trading.
OtherBenzingaSector and industry: HealthcareBiotechnologyTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
Moderna (MRNA) shares are trending after hours following an announcement regarding its investigational mRNA-based individualized neoantigen therapy, intismeran autogene. The company will present three abstracts, including Phase 3 trial data evaluating intismeran with Merck & Co.'s (MRK) pembrolizumab, at the European Society for Medical Oncology Congress 2026. MRNA stock saw a significant jump of 6.98% during regular trading and edged higher in after-hours trading.
Article tone: Positive This describes the words the journalist used. It is not a prediction, and not advice.
Also mentioned:MRK
Published Sep 24, 2026, 22:55 ET · on this site +2d 2h